Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Pro Medicus Limited ( (AU:PME) ) just unveiled an update.
Pro Medicus Limited has announced an update on its ongoing on-market buy-back program, with a total of 39,001 securities bought back before the previous day and an additional 2,138 securities acquired on the previous day. This buy-back initiative reflects the company’s strategy to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$350.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, providing advanced imaging software and services primarily for radiology departments. The company focuses on delivering innovative solutions that enhance medical imaging and streamline healthcare operations.
Average Trading Volume: 174,613
Technical Sentiment Signal: Buy
Current Market Cap: A$25.78B
Find detailed analytics on PME stock on TipRanks’ Stock Analysis page.